Hereditary Tyrosinemia Type 1 (HT-1) Dietitian Training

Develop your expertise in HT-1 nutrition management

Tuesday, September 15th, 2026


12:30 pm ET | 9:30 am PTOnline via Zoom

Join this expert‑led interactive meeting to advance your understanding of nutritional management for patients with HT-1.

HT-1 is an ultra-rare disease, with patients and their caregivers requiring specialized support and guidance to manage their complex dietary requirements throughout their lives.

In this meeting, Kacie Krol and Lindsay Schumacher, experienced dietitians and Cycle Vita™ Clinical Education Managers, will discuss how you can provide this support for your patients, from newborns through to adulthood.

Who should attend

This meeting is intended for:
  • Newly registered dietitians working in metabolic clinics
  • Dietitians new to HT-1
  • Existing dietitians looking to refresh or strengthen their knowledge

What you’ll learn

By attending this meeting, you will:
  • Build a foundational understanding of HT-1
  • Explore treatment principles, including dietary management and clinical goals
  • Understand the challenges of adherence and long‑term patient support
  • Gain practical insight into managing nutrition from infancy through to adulthood
  • Learn how to access additional support through Cycle Vita programs

The speakers

Kacie Krol – RD
Clinical Education Manager, Cycle Vita

Lindsay Schumacher – RDN
Senior Clinical Education Manager, Cycle Vita

Kacie and Lindsay bring a wealth of experience and knowledge to their roles as Clinical Education Managers, empowering patients by providing expert guidance and serving as advocates.

One-to-one dietitian support

This meeting is part of the Cycle Vita Dietitian training support that we offer to all metabolic clinics. To find out more, contact us at hello@cyclevita.life or 888-360-8482.

Terms and conditions

By ticking the consent box, I agree to give Cycle Pharmaceuticals, its affiliates, subsidiaries, and business partners permission to use and disclose the personal information provided in this registration form, as described in this authorization. I authorize Cycle Pharmaceuticals and its service providers to contact me regarding Cycle Pharmaceuticals’ products, services, and programs via email, text, or phone (including using an automatic dialing system) based on the communication methods I have selected.

All personal information will be processed by or on behalf of Cycle Pharmaceuticals to deliver relevant marketing communications. Cycle Pharmaceuticals will retain personal information only for as long as it is required to complete the purposes for which it was collected and to fulfill its legal, regulatory and reporting obligations.

I understand that the information I am providing may be used by Cycle Pharmaceuticals to provide me with health and product information and related services concerning health conditions and treatments, and that Cycle Pharmaceuticals will treat my information in accordance with its Privacy Policy. I acknowledge that I am submitting this form voluntarily, and that I am at least 18 years of age. I understand I can opt out of receiving communications from Cycle Pharmaceuticals at any time by emailing marketing@cyclepharma.com.

Information you provide when registering will be shared with the account owner and host and can be used and shared by them in accordance with their Terms and Privacy Policy.

This educational webinar is sponsored and hosted by Cycle Pharmaceuticals.

Cycle Vita™ is a trademark of Cycle Pharmaceuticals Limited in the United States.

Cycle Pharma Logo Light

CYCLE Pharmaceuticals Limited is registered in England and Wales. Registration number 07933058.

Modern Slavery Statement
Head Office (UK)

Cycle Pharmaceuticals Ltd
The Broers Building
21 JJ Thomson Ave
Cambridge, CB3 0FA
United Kingdom

+44 1223 354118

US Office

Cycle Pharmaceuticals Inc.
19 Clifford St
Detroit, MI 48226
United States

+1 800 903 1793

US Office

Cycle Pharmaceuticals Inc.
200 Portland St
Boston, MA 02114
United States

+1 800 903 1793

© 2026 Cycle Pharmaceuticals Limited. All rights reserved.

US-VITA-2600031 | July 2026
Follow us